GRTS - Gritstone bio, Inc.
IEX Last Trade
0.0327
-2.422 -7,407.645%
Share volume: 0
Last Updated: Mon 21 Oct 2024 08:09:01 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$2.46
-2.42
-98.67%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-03-09 | 2023-05-11 | 2023-08-09 | 2023-11-08 | 2024-03-05 | 2024-05-09 | |
| Total revenue | 5.471 M | 3.021 M | 4.262 M | 2.443 M | 1.955 M | 1.565 M | 10.381 M | 1.742 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 5.471 M | 3.021 M | 4.262 M | 2.443 M | 1.955 M | 1.565 M | 10.381 M | 1.742 M | |
| -44.78% | 41.08% | -42.68% | -19.98% | -19.95% | 563.32% | -83.22% | |||
| Operating expenses | 35.139 M | 32.898 M | 36.182 M | 37.259 M | 37.683 M | 40.169 M | 40.854 M | 41.543 M | |
| Selling general and admin | 7.792 M | 6.462 M | 6.761 M | 6.745 M | 6.716 M | 7.406 M | 7.916 M | 8.502 M | |
| Research and development | 27.347 M | 26.436 M | 29.421 M | 30.514 M | 30.967 M | 32.763 M | 32.938 M | 33.041 M | |
| Total expenses | 35.139 M | 32.898 M | 36.182 M | 37.259 M | 37.683 M | 40.169 M | 40.854 M | 41.543 M | |
| -6.38% | 9.98% | 2.98% | 1.14% | 6.60% | 1.71% | 1.69% | |||
| Operating income | -29.668 M | -29.877 M | -31.920 M | -34.816 M | -35.728 M | -38.604 M | -30.473 M | -39.801 M | |
| Ebit | -29.668 M | -29.877 M | -31.920 M | -34.816 M | -35.728 M | -38.604 M | -30.473 M | -39.801 M | |
| Pretax income | -29.515 M | -29.966 M | -31.290 M | -33.982 M | -35.256 M | -38.434 M | -30.818 M | -40.385 M | |
| 1.53% | 4.42% | 8.60% | 3.75% | 9.01% | -19.82% | 31.04% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -29.515 M | -29.966 M | -31.290 M | -33.982 M | -35.256 M | -38.434 M | -30.818 M | -40.385 M | |
| -1.53% | -4.42% | -8.60% | -3.75% | -9.01% | 19.82% | -31.04% | |||
| Net income | -29.515 M | -29.966 M | -31.290 M | -33.982 M | -35.256 M | -38.434 M | -30.818 M | -40.385 M | |
| -1.53% | -4.42% | -8.60% | -3.75% | -9.01% | 19.82% | -31.04% |